Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-12

Clinical Trial Update: BOTOX® Prophylaxis in Patients With Chronic Migraine

View source ↗

Summary

Clinical trial update on BOTOX prophylaxis in chronic migraine patients; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Migraine Disorders | Status: COMPLETED | Results posted: 2016-12-12